Foley Hoag is pleased to host CannabizMD and the Boston Cannabis Science + Policy Forum on Patient Care, Policy, and Emerging Trends. This innovative event for New England-based physicians, advanced practice providers and medical cannabis industry professionals will feature roundtable discussions focused on the science and therapeutic use of medical cannabis, and the emerging trends and innovation in medical cannabis.

Foley Hoag partner Bryant Godfrey will participate in a roundtable discussion on "Federal Regulatory Considerations for Clinical Practice and Research," exploring the complex federal regulatory landscape, the likely next steps for federal cannabis drug policy reform, the impact of the 2022 Medical Marijuana and Cannabidiol Research Expansion Act and federal DE&I initiatives.

Partner Kevin Conroy will participate in a roundtable discussion on "State Regulatory Considerations" exploring whether state programs are effective at supporting the communities most harmed by the War on Drugs, and the impact of state adult-use legalization on state medical cannabis programs including the costs and benefits and the success of social equity initiatives.